enVVeno Medical Corporation Common Stock (NVNO) Stock Price

NVNOStock

$10.80−74.73%52W

Market Cap$7.50M

P/E—

PEG Ratio—

Div yield—

Beta1.23

NVNO Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-0.25%

Price vs S&P 500 (4W)-3.53%

VGM Score31.99

Book Value / Share (Quarterly)$30.71

P/TBV (Annual)1.31x

Indicated Dividend (Annual)$0.00

Cash Flow / Share (Quarterly)$-21.73

Price vs S&P 500 (YTD)-18.85%

Gross Margin (TTM)100.00%

Net Profit Margin (TTM)-5483.33%

EPS (TTM)$-25.19

10-Day Avg Trading Volume0.02M

EPS Excl Extra (TTM)$-25.19

EPS (Annual)$-1.29

ROI (Annual)-52.18%

Gross Margin (Annual)100.00%

Net Profit Margin (5Y Avg)-7032.74%

Cash / Share (Quarterly)$31.93

ROA (Last FY)-48.94%

EBITD / Share (TTM)$-26.47

ROE (5Y Avg)-65.39%

Operating Margin (TTM)-4461.11%

Cash Flow / Share (Annual)$-23.74

P/B Ratio0.36x

P/B Ratio (Quarterly)0.35x

Net Income / Employee (Annual)$-666,700

Net Interest Coverage (TTM)-117.55x

ROA (TTM)-56.83%

EPS Incl Extra (Annual)$-1.29

Current Ratio (Annual)13.58x

Quick Ratio (Quarterly)11.39x

3-Month Avg Trading Volume0.02M

52-Week Price Return-74.73%

Revenue / Employee (TTM)$0

Tangible BV / Share (Quarterly)$2.63

P/S Ratio (Annual)247.03x

Asset Turnover (Annual)0.01x

52-Week High$49.35

Operating Margin (5Y Avg)-6266.24%

EPS Excl Extra (Annual)$-1.29

CapEx CAGR (5Y)-51.16%

26-Week Price Return10.99%

Quick Ratio (Annual)13.29x

13-Week Price Return-5.48%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)11.70x

Enterprise Value$4.57M

Asset Turnover (TTM)0.03x

Revenue / Employee (Annual)$0

Pretax Margin (Annual)-25433.33%

Cash / Share (Annual)$43.01

3-Month Return Std Dev65.08%

Net Income / Employee (TTM)$-476,500

ROE (Last FY)-52.18%

Net Interest Coverage (Annual)-87.25x

EPS Basic Excl Extra (Annual)$-1.29

Receivables Turnover (TTM)2.00x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-25.19

Receivables Turnover (Annual)2.00x

ROI (TTM)-62.28%

P/S Ratio (TTM)41.17x

Pretax Margin (5Y Avg)-7056.77%

Revenue / Share (Annual)$0.00

Tangible BV / Share (Annual)$4.09

Price vs S&P 500 (52W)-93.04%

Year-to-Date Return-7.84%

5-Day Price Return-6.21%

EPS Normalized (Annual)$-1.29

ROA (5Y Avg)-54.58%

Net Profit Margin (Annual)-25433.33%

Month-to-Date Return-2.36%

Cash Flow / Share (TTM)$-2.12

EBITD / Share (Annual)$-1.40

Operating Margin (Annual)-25600.00%

ROI (5Y Avg)-64.31%

EPS Basic Excl Extra (TTM)$-25.19

P/TBV (Quarterly)2.03x

P/B Ratio (Annual)0.24x

Inventory Turnover (TTM)9.33x

Pretax Margin (TTM)-5483.33%

Book Value / Share (Annual)$41.36

Price vs S&P 500 (13W)-8.27%

Beta1.23x

P/FCF (Annual)82.34x

Revenue / Share (TTM)$0.00

ROE (TTM)-62.28%

52-Week Low$8.67

mGradeD

vgmGradeD

NVNO Earnings Surprise History

Q2 25-11.55est. -9.80

Q1 26-5.89est. —

Q2 26-5.37est. -4.69

NVNO Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

2.17

4.29

Industry Peers — Surgical & Medical Instruments(140)

Symbol	Value Score	Growth Score	Momentum Score	Price
NVNOenVVeno Medical Corporation Common Stock	—	—	D	$10.80
SYKStryker Corporation	C	B	C	$330.59
MMM3M Company	C	D	B	$179.37
BSXBoston Scientific Corp.	C	B	D	$49.86
BDXBecton, Dickinson and Co.	B	D	B	$189.78
MDLNMedline Inc. Class A common stock	C	D	C	$35.64
RMDResMed Inc.	C	B	C	$236.59
DXCMDexCom, Inc.	D	B	B	$89.16
WSTWest Pharmaceutical Services, Inc.	D	C	B	$348.48
SOLVSolventum Corporation	C	C	B	$91.61
BAXBaxter International Inc.	B	D	B	$26.29
PENPenumbra, Inc.	D	C	C	$324.37
GMEDGLOBUS MEDICAL INC	B	B	C	$82.96
GKOSGlaukos Corporation	F	A	A	$181.39
PODDInsulet Corporation	C	A	D	$143.05
STVNStevanato Group S.p.A.	D	C	B	$22.70
TFXTeleflex Incorporated	B	F	B	$140.18
MMSIMerit Medical Systems Inc	C	B	B	$91.09
MMEDMiniMed Group, Inc. Common Stock	—	—	A	$18.92
HAEHaemonetics Corporation	C	C	A	$108.32
ICUIICU Medical Inc	C	D	B	$182.24
HTFLHeartflow, Inc. Common Stock	—	A	A	$49.89
IRTCiRhythm Holdings, Inc. Common Stock	F	A	C	$123.09
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	$49.00
ATRCAtriCure, Inc.	D	B	A	$48.68
UFPTUFP Technologies Inc	C	B	B	$304.21
NVCRNovoCure Limited Ordinary Shares	D	C	C	$17.62
LMATLeMaitre Vascular, Inc.	C	B	D	$78.97
INSPInspire Medical Systems, Inc.	B	B	B	$61.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	$26.92
TNDMTandem Diabetes Care, Inc.	D	C	B	$21.58
ATECAlphatec Holdings, Inc.	D	B	C	$9.33
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	A	$14.70
IARTIntegra LifeSciences Holdings	B	D	C	$16.79
AORTArtivion, Inc.	C	C	C	$26.38
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	$21.60
IRMDiRadimed Corporation	D	B	C	$87.87
BVSBioventus Inc. Class A Common Stock	B	C	A	$14.08
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	$26.60
SIBNSI-BONE, Inc. Common Stock	D	B	B	$19.54
BBNXBeta Bionics, Inc. Common Stock	D	A	A	$19.34
SSIISS Innovations International Inc. Common Stock	F	A	D	$3.55
ANGOAngioDynamics, Inc.	C	D	B	$15.95
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	$24.50
MDXGMiMedx Group, Inc	C	D	C	$4.34
DCTHDelcath Systems Inc	D	B	A	$16.92
BWAYBrainsway Ltd. American Depositary Shares	F	A	C	$14.43
CERSCerus Corp	D	C	B	$2.72
TCMDTactile Systems Technology, Inc.	B	B	C	$23.58
CLPTClearPoint Neuro, Inc. Common Stock	F	A	B	$16.96
NPCENeuropace, Inc. Common Stock	D	C	C	$14.16

About enVVeno Medical Corporation Common Stock

enVVeno Medical Corp develops bioprosthetic venous valve replacements to treat venous disease. The company's lead product, VenoValve, is a surgical replacement currently in a U.S. pivotal trial, while its pipeline includes enVVe, a non-surgical transcatheter option. Both products are designed to restore valve function and improve blood circulation in the legs.